Bolar Pharmaceutical
Executive Summary
Melvin Sharoky, MD, formerly Bolar's medical director has been named senior VP and director of R&D of the company. As medical director, Sharoky was responsible for new drug development programs. Bolar is consolidating new drug and generics R&D under Sharoky's purview. He will transfer from Bolar's new drug research offices in Baltimore, Maryland to the company's headquarters in Copiague, New York.